PMV Pharmaceuticals, Inc.PMVPNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.5%
5Y CAGR+24.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+10.5%/yr
vs +39.0%/yr prior
5Y CAGR
+24.2%/yr
Recent deceleration
Acceleration
-28.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $69.78M | +21.6% |
| 2024 | $57.38M | +5.0% |
| 2023 | $54.63M | +5.7% |
| 2022 | $51.67M | +42.8% |
| 2021 | $36.19M | +53.2% |
| 2020 | $23.61M | +13.8% |
| 2019 | $20.76M | +49.9% |
| 2018 | $13.85M | - |